Decheng Capital Management III (Cayman)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$9.13M Hold
78,900
3.05% 12
2023
Q2
$8.11M Hold
78,900
2.55% 11
2023
Q1
$8.61M Hold
78,900
3.47% 10
2022
Q4
$8.98M Hold
78,900
3.36% 11
2022
Q3
$4.88M Buy
78,900
+23,500
+42% +$1.45M 1.77% 16
2022
Q2
$4.42M Buy
+55,400
New +$4.42M 1.68% 14